Tag Archives: GlobalPharma

Health Care

Globalpharma and UNIMED Sign Strategic Distribution Agreement at World Health Expo 2026

Partnership expands access to high quality UAE made medicines through enhanced national distribution capabilities

DUBAI, UAE, February 16th 2026 — Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has announced the signing of a strategic distribution agreement with United Medical Supplies (UNIMED) LLC, a key healthcare distributor under the Mohamed & Obaid Al Mulla Group. The agreement was formalized at the World Health Expo (WHX) 2026.

The collaboration marks an important step in expanding the reach of Globalpharma’s locally manufactured medicines across the UAE. By leveraging UNIMED’s extensive distribution network and capabilities, the partnership will enhance market access for Globalpharma’s expanding portfolio — including its 25 newly launched products — ensuring greater availability across pharmacies, hospitals, and key healthcare channels.

Continue reading Globalpharma and UNIMED Sign Strategic Distribution Agreement at World Health Expo 2026 →
Business & Investments

Globalpharma Inks 4 Strategic MoUs during ‘Make it in the Emirates 2025’ to Boost Pharma Localization and Innovation in the UAE

“These partnerships are enhancing the country’s position as a global hub for high-quality, future-ready healthcare solutions” – Dr. Thani Al Zeyoudi

Abu Dhabi, UAE – 22nd May 2025 – Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has signed 4 strategic Memorandums of Understanding (MoUs) during the Make it in the Emirates Forum 2025. The agreements reinforce the UAE’s position as a regional hub for pharmaceutical innovation, localization, and advanced healthcare manufacturing.

Continue reading Globalpharma Inks 4 Strategic MoUs during ‘Make it in the Emirates 2025’ to Boost Pharma Localization and Innovation in the UAE →
Business & Investments

Globalpharma Partners with ZIM Laboratories to Revolutionize Oral Drug Technology in the UAE

8th April, Dubai, UAE – Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has collaborated with India’s ZIM Laboratories to bring EU-certified Oral Dispersible Film (ODF) technology to its growing portfolio. This innovative drug technology has already received EU Good Manufacturing Practice (EU-GMP) certification, ensuring it meets the highest international quality and safety standards.

The agreement, unveiled at AIM Congress 2025 (7-9 April), underscores the UAE’s growing influence in global pharmaceutical innovation and its commitment to cutting-edge healthcare solutions.

Continue reading Globalpharma Partners with ZIM Laboratories to Revolutionize Oral Drug Technology in the UAE →
Business & Investments

GlobalPharma captures 1.8% market share, marking unprecedented growth in Saudi Arabia

Globalpharma’s sales in the Saudi pharmaceutical market surged by 139.5% year-over-year in May 2024, reaching $12.6M up from $5.2M in 2023

Dubai, UAE, 27 August 2024: Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, today announced a significant milestone by capturing a 1.8% market share in the competitive Saudi pharmaceutical landscape. As of May 2024, Globalpharma’s sales surged by 139.5% year-over-year, reaching $12.6 million up from $5.2 million in the same period last year.

Continue reading GlobalPharma captures 1.8% market share, marking unprecedented growth in Saudi Arabia →